Ketamine Hydrochloride for Opioid Use Disorder

"There is some data supporting Ketamine Hydrochloride's safety, but none suggesting that it is an effective medication. It received a score of 2."

"The clinical trial is seeking 30 participants and is actively recruiting, according to the information available on clinicaltrials.gov. The study was posted on December 17th, 2020 and updated January 7th, 2022."

"The clinical trial is still active and looking for participants, as the information on clinicaltrials.gov indicates. The study was first posted on December 17th 2020, with the most recent update being January 7th of 2022. They are recruiting 30 individuals from 1 location."

"The age range of 18 to 65 is an inclusion criterion for this particular study. There are 516 other trials available for minors and 1883 studies that senior citizens can participate in."

"This study is looking for 30 patients that have depression and use opioids. The trial requirements are as follows: Subjects must be considered to have treatment-refractory MDD as evidenced by failure or only partial response to treatment with at least two standard of care pharmacotherapy antidepressants., Have used opioids illicitly at least once in the past month., Between the ages of 18 to 65 years old., Able to provide informed consent., Meet DSM-5 criteria for Major Depressive Disorder, without psychotic features., Score at least 20 on the Montgomery-Asberg Depression Rating Scale., Fulfill a minimum of 4 of 11 current opioid use disorder"